在三阴性乳腺癌中,RAL小G蛋白是临床相关的标
David Han1, Jonathan M Spehar1, Dillon S Richardson1
1Department of Radiation Oncology, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
研究人员确定了RAL蛋白作为三阴性乳腺癌 (TNBC) 的潜在标. 一种新的抑制剂,OSURALi,在向RAL-依赖的TNBC细胞方面表现有前途,提供了潜在的新疗法途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 乳腺癌 (BC) 是女性癌症死亡的主要原因.
- 在三阴性 (TNBC) 和HER2阳性 (HER2+) 乳腺癌亚型中,RAS通路的激活是常见的.
- RAL蛋白 (RALA和RALB) 在BC中过度表达,是RAS的下游作用者.
研究的目的:
- 研究RALA和RALB作为TNBC和HER2+BC中的分子标.
- 评估现有的RAL抑制剂,并发现用于BC治疗的新药.
主要方法:
- 对乳腺癌患者样本数据的分析.
- 在使用BC细胞系的体内和体外实验.
- 对RAL抑制剂 (RBC8,BQU57,OSURALi) 的测试.
主要成果:
- 拉尔蛋白与TNBC和HER2+BC的不良结果有关.
- RALs对于TNBC细胞生存至关重要,但不是HER2+BC.
- 现有的RAL抑制剂与RAL依赖性没有相关性,这表明非目标效应.
- 新型抑制剂OSURALi有效向RAL激活,对依赖RAL的TNBC细胞有毒.
结论:
- 拉尔蛋白是特别适用于TNBC的可行的分子标.
- 欧苏拉利显示出作为TNBC治疗剂的潜力,需要进一步调查.
更多相关视频
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
相关概念视频
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
GTPases and their Regulation
Large G-proteins,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
